
Carlsmed Projects 2026 Revenue Up to $78 Million Following CMS Aprevo Lumbar DRG Finalization
Carlsmed Inc. has issued a 2026 revenue outlook of $74 million to $78 million, driven by the recent finalization of new aprevo lumbar MS-DRGs by CMS. These new classifications are set to become…










